Selected research
Industry Research
Desloratadine API Industry Research Report 2026
Market perspective
The global Desloratadine API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Desloratadine API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Desloratadine API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Desloratadine API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Desloratadine API include Ambica Chemicals, Anant Pharmaceuticals Pvt. Ltd., Cadila Pharmaceuticals, Conscientia Industrial Co Ltd, Dr. Reddy’s Laboratories Ltd., Enomark Pharma, Morepen Laboratories, Sandoo Pharmaceuticals and Chemicals Co.,Ltd. and Tagoor Labs, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Desloratadine API market in terms of revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Desloratadine API Market by Company
Ambica Chemicals
Anant Pharmaceuticals Pvt. Ltd.
Cadila Pharmaceuticals
Conscientia Industrial Co Ltd
Dr. Reddy’s Laboratories Ltd.
Enomark Pharma
Morepen Laboratories
Sandoo Pharmaceuticals and Chemicals Co.,Ltd.
Tagoor Labs
Taj Pharmaceuticals Ltd
Vasudha Pharma
Chengdu Yinuo Pharmchem Co., Ltd.
Hainan Poly Pharm. Co., Ltd.
Sun Pharma
Desloratadine API Segment by Type
Purity≥99%
Purity<99%
Desloratadine API Segment by Application
Syrup
Tablet
Oral Solution
Capsule
Others
Desloratadine API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Desloratadine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Desloratadine API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Desloratadine API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Desloratadine API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Desloratadine API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Desloratadine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity≥99%
- Purity<99%
Applications
- Syrup
- Tablet
- Oral Solution
- Capsule
- Others
Companies covered
- Ambica Chemicals
- Anant Pharmaceuticals Pvt. Ltd.
- Cadila Pharmaceuticals
- Conscientia Industrial Co Ltd
- Dr. Reddy’s Laboratories Ltd.
- Enomark Pharma
- Morepen Laboratories
- Sandoo Pharmaceuticals and Chemicals Co.,Ltd.
- Tagoor Labs
- Taj Pharmaceuticals Ltd
- Vasudha Pharma
- Chengdu Yinuo Pharmchem Co., Ltd.
- Hainan Poly Pharm. Co., Ltd.
- Sun Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Desloratadine API Market Size (2021-2032)
- 2.2.2 Global Desloratadine API Sales (2021-2032)
- 2.2.3 Global Desloratadine API Market Average Price (2021-2032)
- 2.3 Desloratadine API by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Purity≥99%
- 2.3.3 Purity<99%
- 2.4 Desloratadine API by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Syrup
- 2.4.3 Tablet
- 2.4.4 Oral Solution
- 2.4.5 Capsule
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Desloratadine API Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Desloratadine API Sales (t) of Manufacturers (2021-2026)
- 3.3 Global Desloratadine API Revenue of Manufacturers (2021-2026)
- 3.4 Global Desloratadine API Average Price by Manufacturers (2021-2026)
- 3.5 Global Desloratadine API Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Desloratadine API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Desloratadine API, Product Type & Application
- 3.8 Global Manufacturers of Desloratadine API, Established Date
- 3.9 Global Desloratadine API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Ambica Chemicals
- 4.1.1 Ambica Chemicals Company Information
- 4.1.2 Ambica Chemicals Business Overview
- 4.1.3 Ambica Chemicals Desloratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Ambica Chemicals Desloratadine API Product Portfolio
- 4.1.5 Ambica Chemicals Recent Developments
- 4.2 Anant Pharmaceuticals Pvt. Ltd.
- 4.2.1 Anant Pharmaceuticals Pvt. Ltd. Company Information
- 4.2.2 Anant Pharmaceuticals Pvt. Ltd. Business Overview
- 4.2.3 Anant Pharmaceuticals Pvt. Ltd. Desloratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Anant Pharmaceuticals Pvt. Ltd. Desloratadine API Product Portfolio
- 4.2.5 Anant Pharmaceuticals Pvt. Ltd. Recent Developments
- 4.3 Cadila Pharmaceuticals
- 4.3.1 Cadila Pharmaceuticals Company Information
- 4.3.2 Cadila Pharmaceuticals Business Overview
- 4.3.3 Cadila Pharmaceuticals Desloratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Cadila Pharmaceuticals Desloratadine API Product Portfolio
- 4.3.5 Cadila Pharmaceuticals Recent Developments
- 4.4 Conscientia Industrial Co Ltd
- 4.4.1 Conscientia Industrial Co Ltd Company Information
- 4.4.2 Conscientia Industrial Co Ltd Business Overview
- 4.4.3 Conscientia Industrial Co Ltd Desloratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Conscientia Industrial Co Ltd Desloratadine API Product Portfolio
- 4.4.5 Conscientia Industrial Co Ltd Recent Developments
- 4.5 Dr. Reddy’s Laboratories Ltd.
- 4.5.1 Dr. Reddy’s Laboratories Ltd. Company Information
- 4.5.2 Dr. Reddy’s Laboratories Ltd. Business Overview
- 4.5.3 Dr. Reddy’s Laboratories Ltd. Desloratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Dr. Reddy’s Laboratories Ltd. Desloratadine API Product Portfolio
- 4.5.5 Dr. Reddy’s Laboratories Ltd. Recent Developments
- 4.6 Enomark Pharma
- 4.6.1 Enomark Pharma Company Information
- 4.6.2 Enomark Pharma Business Overview
- 4.6.3 Enomark Pharma Desloratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Enomark Pharma Desloratadine API Product Portfolio
- 4.6.5 Enomark Pharma Recent Developments
- 4.7 Morepen Laboratories
- 4.7.1 Morepen Laboratories Company Information
- 4.7.2 Morepen Laboratories Business Overview
- 4.7.3 Morepen Laboratories Desloratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Morepen Laboratories Desloratadine API Product Portfolio
- 4.7.5 Morepen Laboratories Recent Developments
- 4.8 Sandoo Pharmaceuticals and Chemicals Co.,Ltd.
- 4.8.1 Sandoo Pharmaceuticals and Chemicals Co.,Ltd. Company Information
- 4.8.2 Sandoo Pharmaceuticals and Chemicals Co.,Ltd. Business Overview
- 4.8.3 Sandoo Pharmaceuticals and Chemicals Co.,Ltd. Desloratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sandoo Pharmaceuticals and Chemicals Co.,Ltd. Desloratadine API Product Portfolio
- 4.8.5 Sandoo Pharmaceuticals and Chemicals Co.,Ltd. Recent Developments
- 4.9 Tagoor Labs
- 4.9.1 Tagoor Labs Company Information
- 4.9.2 Tagoor Labs Business Overview
- 4.9.3 Tagoor Labs Desloratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Tagoor Labs Desloratadine API Product Portfolio
- 4.9.5 Tagoor Labs Recent Developments
- 4.10 Taj Pharmaceuticals Ltd
- 4.10.1 Taj Pharmaceuticals Ltd Company Information
- 4.10.2 Taj Pharmaceuticals Ltd Business Overview
- 4.10.3 Taj Pharmaceuticals Ltd Desloratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Taj Pharmaceuticals Ltd Desloratadine API Product Portfolio
- 4.10.5 Taj Pharmaceuticals Ltd Recent Developments
- 4.11 Vasudha Pharma
- 4.11.1 Vasudha Pharma Company Information
- 4.11.2 Vasudha Pharma Business Overview
- 4.11.3 Vasudha Pharma Desloratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Vasudha Pharma Desloratadine API Product Portfolio
- 4.11.5 Vasudha Pharma Recent Developments
- 4.12 Chengdu Yinuo Pharmchem Co., Ltd.
- 4.12.1 Chengdu Yinuo Pharmchem Co., Ltd. Company Information
- 4.12.2 Chengdu Yinuo Pharmchem Co., Ltd. Business Overview
- 4.12.3 Chengdu Yinuo Pharmchem Co., Ltd. Desloratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Chengdu Yinuo Pharmchem Co., Ltd. Desloratadine API Product Portfolio
- 4.12.5 Chengdu Yinuo Pharmchem Co., Ltd. Recent Developments
- 4.13 Hainan Poly Pharm. Co., Ltd.
- 4.13.1 Hainan Poly Pharm. Co., Ltd. Company Information
- 4.13.2 Hainan Poly Pharm. Co., Ltd. Business Overview
- 4.13.3 Hainan Poly Pharm. Co., Ltd. Desloratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Hainan Poly Pharm. Co., Ltd. Desloratadine API Product Portfolio
- 4.13.5 Hainan Poly Pharm. Co., Ltd. Recent Developments
- 4.14 Sun Pharma
- 4.14.1 Sun Pharma Company Information
- 4.14.2 Sun Pharma Business Overview
- 4.14.3 Sun Pharma Desloratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Sun Pharma Desloratadine API Product Portfolio
- 4.14.5 Sun Pharma Recent Developments
5 Global Desloratadine API Market Scenario by Region
- 5.1 Global Desloratadine API Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Desloratadine API Sales by Region: 2021-2032
- 5.2.1 Global Desloratadine API Sales by Region: 2021-2026
- 5.2.2 Global Desloratadine API Sales by Region: 2027-2032
- 5.3 Global Desloratadine API Revenue by Region: 2021-2032
- 5.3.1 Global Desloratadine API Revenue by Region: 2021-2026
- 5.3.2 Global Desloratadine API Revenue by Region: 2027-2032
- 5.4 North America Desloratadine API Market Facts & Figures by Country
- 5.4.1 North America Desloratadine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Desloratadine API Sales by Country (2021-2032)
- 5.4.3 North America Desloratadine API Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Desloratadine API Market Facts & Figures by Country
- 5.5.1 Europe Desloratadine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Desloratadine API Sales by Country (2021-2032)
- 5.5.3 Europe Desloratadine API Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Desloratadine API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Desloratadine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Desloratadine API Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Desloratadine API Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Desloratadine API Market Facts & Figures by Country
- 5.7.1 South America Desloratadine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Desloratadine API Sales by Country (2021-2032)
- 5.7.3 South America Desloratadine API Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Desloratadine API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Desloratadine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Desloratadine API Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Desloratadine API Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Desloratadine API Sales by Type (2021-2032)
- 6.1.1 Global Desloratadine API Sales by Type (2021-2032) & (t)
- 6.1.2 Global Desloratadine API Sales Market Share by Type (2021-2032)
- 6.2 Global Desloratadine API Revenue by Type (2021-2032)
- 6.2.1 Global Desloratadine API Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Desloratadine API Revenue Market Share by Type (2021-2032)
- 6.3 Global Desloratadine API Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Desloratadine API Sales by Application (2021-2032)
- 7.1.1 Global Desloratadine API Sales by Application (2021-2032) & (t)
- 7.1.2 Global Desloratadine API Sales Market Share by Application (2021-2032)
- 7.2 Global Desloratadine API Revenue by Application (2021-2032)
- 7.2.1 Global Desloratadine API Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Desloratadine API Revenue Market Share by Application (2021-2032)
- 7.3 Global Desloratadine API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Desloratadine API Value Chain Analysis
- 8.1.1 Desloratadine API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Desloratadine API Production Mode & Process
- 8.2 Desloratadine API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Desloratadine API Distributors
- 8.2.3 Desloratadine API Customers
9 Global Desloratadine API Analyzing Market Dynamics
- 9.1 Desloratadine API Industry Trends
- 9.2 Desloratadine API Industry Drivers
- 9.3 Desloratadine API Industry Opportunities and Challenges
- 9.4 Desloratadine API Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst